UK publishes interim guide for stem cell research and manufacture
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has published an interim regulatory route map as a reference tool for those wishing to embark on a programme of stem cell research and manufacture that will ultimately lead to clinical application1. A more detailed, web-based version of the map is currently being developed and will be available by the end of 2009. The interim map has been developed by the Department of Health with the support of the Gene Therapy Advisory Committee, and other relevant UK regulatory bodies.